Back to Stocks
Stock detail
Biogen Inc.
BIIBSTOCKS | US | NASDAQ | Healthcare | Drug Manufacturers - General
Profile snapshotUSD 205.6Market cap USD 30.4B
No local candle data found.
Recent detected patterns / setups
Latest 10 Market Radar results for this symbol.
PatternTFDetectedQuality
BearishOrder Block Setup15M28 Jul 26, 15:4575
BullishMA 21/55 Crossover15M28 Jul 26, 15:4581
BullishOliver Kell Momentum Setup15M28 Jul 26, 15:4582
BullishMA 8/21 Crossover15M28 Jul 26, 15:4584
BullishFVG Reaction Setup15M + 15M28 Jul 26, 15:4591
BearishOrder Block Setup4H28 Jul 26, 13:3077
BullishOliver Kell Momentum Setup4H28 Jul 26, 13:3081
BullishMA 8/21 Crossover4H28 Jul 26, 13:3084
BearishOrder Block Setup1D28 Jul 26, 00:0078
BullishDouble Bottom15M28 Jul 26, 15:4564
Annual
Annual fundamentals
2025 vs previous annual period
Metric202020212022202320242025
Total revenueUSD 13.4B-6.5%USD 11B-18.3%USD 10.2B-7.4%USD 9.8B-3.3%USD 9.7B-1.6%USD 9.8B+1.4%
Net incomeUSD 4B-32.1%USD 1.6B-61.1%USD 3B+95.8%USD 1.2B-61.9%USD 1.6B+40.6%USD 1.3B-20.8%
Net profit margin29.8%-27.3%14.2%-52.4%29.9%+111.4%11.8%-60.6%16.9%+42.9%13.2%-21.8%
EPS24.86-21.0%10.44-58.0%20.97+100.9%8.02-61.8%11.2+39.7%8.85-21.0%
Quarterly
Quarterly fundamentals
Q1 2026 vs same quarter previous year
MetricQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026
Total revenueUSD 2.5B+2.9%USD 2.4B+6.1%USD 2.6B+7.3%USD 2.5B-0.4%USD 2.3B-7.1%USD 2.5B+1.9%
Net incomeUSD 266.7M+6.8%USD 240.5M-38.9%USD 634.8M+8.8%USD 466.5M+20.1%USD -48.4M-118.2%USD 319.5M+32.8%
Net profit margin10.9%+3.8%9.9%-42.4%24.0%+1.3%19.0%+20.6%-2.1%-119.5%12.9%+30.3%
EPS1.83+6.4%1.65-39.1%4.35+8.5%3.18+19.1%-0.33-118.0%2.17+31.5%
Ownership
Institutional ownership summary
2026 Q2, quarter ended 2026-06-30
PeriodOwnershipInstitutions13F sharesTotal investedPositionsPut/call
2026 Q22026-06-30